Low-molecular-weight heparin in pregnant women with prosthetic heart valves

Journal of Heart Valve Disease

Volumn 15, Issue 5, 2006, Pages 679-685

  Descarries, Laurence M ^a   Leduc, Line ^b   Khairy, Paul ^a   Mercier, Lise Andrée ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; BIOLOGICAL MARKER; FIBRINOLYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; VITAMIN K GROUP;

ADULT; AORTA VALVE; ARTICLE; BLOOD; CANADA; CORONARY ARTERY ATHEROSCLEROSIS; DRUG ANTAGONISM; DRUG COMBINATION; EMBOLISM; FEMALE; HEART INFARCTION; HEART VALVE PROSTHESIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MITRAL VALVE; PREGNANCY; PREGNANCY COMPLICATION; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

ADULT; ANTICOAGULANTS; ANTIFIBRINOLYTIC AGENTS; AORTIC VALVE; ASPIRIN; BIOLOGICAL MARKERS; CORONARY ARTERIOSCLEROSIS; DRUG THERAPY, COMBINATION; EMBOLISM; FEMALE; FIBRINOLYTIC AGENTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTERNATIONAL NORMALIZED RATIO; MITRAL VALVE; MYOCARDIAL INFARCTION; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; QUEBEC; TREATMENT OUTCOME; VITAMIN K;

EID: 34447283220     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Danik S, Fuster V. Anticoagulation in pregnant women with prosthetic heart valves. Mt Sinai J Med 2004;71:322-329
2. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J 1994;71:196-201
3. Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol 1996;27:1698-1703
4. Elkayam U, Singh H, Irani A, Akhter MW. Anticoagulation in pregnant women with prosthetic heart valves. J Cardiovasc Pharmacol Ther 2004;9:107-115
5. Ginsberg JS, Chan WS, Bates SM, Kaatz S. Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med 2003;163:694-698
6. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: A systematic review of the literature. Arch Intern Med 2000;160:191-196
7. Oran B, Lee-Parritz A, Ansell J. Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy. Thromb Haemost 2004;92:747-751
8. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl.):627S-644S
9. Elkayam U, Bitar F. Valvular heart disease and pregnancy. Part II: Prosthetic valves. J Am Coll Cardiol 2005;46:403-410
10. Lavoie JP, Leduc L, Mercier LA. Embolic myocardial infarction in a pregnant woman with a mechanical heart valve on low molecular weight heparin. Can J Cardiol 2004;20:917-919
11. Berndt N, Khan I, Gallo R. A complication in anticoagulation using low-molecular weight heparin in a patient with a mechanical valve prosthesis. Acase report. J Heart Valve Dis 2000;9:844-846
12. Idir M, Madonna F, Roudaut R. Collapse and massive pulmonary edema secondary to thrombosis of a mitral mechanical heart valve prosthesis during low-molecular weight heparin therapy. J Heart Valve Dis 1999;8:303-304
13. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo N. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637-1641
14. Sadler L, McCowan L, White H, Stewart A, Bracken M, North R. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. Br J Obstet Gynaecol 2000;107:245-253
15. Hung L, Rahimtoola SH. Prosthetic heart valves and pregnancy. Circulation 2003;107:1240-1246
16. Geelani MA, Singh S, Verma A, Nagesh A, Betigeri V, Nigam M. Anticoagulation in patients with mechanical valves during pregnancy. Asian Cardiovasc Thorac Ann 2005;13:30-33
17. Denbow CE, Matadial L, Sivapragasam S, Spencer H. Pregnancy in patients after homograft cardiac valve replacement. Chest 1983;83:540-542
18. Ginsberg JS, Barron WM. Pregnancy and prosthetic heart valves. Lancet 1994;344:1170-1172
19. Elkayam U. Pregnancy through a prosthetic heart valve. J Am Coll Cardiol 1999;33:1642-1645
20. Barbour LA. Current concepts of anticoagulant therapy in pregnancy. Obstet Gynecol Clin North Am 1997;24:499-521
21. Hanania G, Thomas D, Michel PL, et al. Pregnancy and prosthetic heart valves: A French cooperative retrospective study of 155 cases. Eur Heart J 1994;15:1651-1658
22. Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997;337:688-698
23. Harenberg J, Huhle G, Piazolo L, Giese C, Heene DL. Long-term anticoagulation of outpatients with adverse events to oral anticoagulants using low-molecular- weight heparin. Semin Thromb Hemost 1997;23:167-172
24. Arnaout MS, Kazma H, Khalil A, et al. Is there a safe anticoagulation protocol for pregnant women with prosthetic valves? Clin Exp Obstet Gynecol 1998;25:101-104
25. Abildgaard U, Gjestvang FT, Lossius P, Hodne E. Low molecular heparin in a pregnant woman with heart valve prosthesis. Tidsskr Nor Laegeforen 1999;119:4319-4320
26. Lev-Ran O, Kramer A, Gurevitch J, Shapira I, Mohr R. Low-molecular-weight heparin for prosthetic heart valves: treatment failure. Ann Thorac Surg 2000;69:265-266
27. Lee LH, Liauw PC, Ng AS. Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement. Thromb Haemost 1996;76:628-630
28. Oles D, Berryessa R, Campbell K, Bhatti MA. Emergency redo mitral valve replacement in a 27-year-old pregnant female with a clotted prosthetic mitral valve, preoperative fetal demise and postoperative ventricular assist device: A case report. Perfusion 2001;16:159-164
29. Rowan JA, McLintock C, Taylor RS, North RA. Prophylactic and therapeutic enoxaparin during pregnancy: Indications, outcomes and monitoring. Aust N Z J Obstet Gynaecol 2003;43:123-128
30. Ellison J, Thomson AJ, Walker ID, Greer IA. Use of enoxaparin in a pregnant woman with a mechanical heart valve prosthesis. Br J Obstet Gynaecol 2001;108:757-759
31. Roberts N, Ross D, Flint SK, Arya R, Blott M. Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparin. Br J Obstet Gynaecol 2001;108:327-329
32. Lindhoff-Last E, Schinzel H, Erbe M, Schachinger V, Bauersachs R. Anticoagulation of pregnant women with mechanical heart valve prostheses. Z Kardiol 2001;90(Suppl.6):125-130
33. Leyh RG, Fischer S, Ruhparwar A, Haverich A. Anticoagulation for prosthetic heart valves during pregnancy: Is low-molecular-weight heparin an alternative? Eur J Cardiothorac Surg 2002;21:577-579
34. Mahesh B, Evans S, Bryan AJ. Failure of low molecular-weight heparin in the prevention of prosthetic mitral valve thrombosis during pregnancy: Case report and a review of options for anticoagulation. J Heart Valve Dis 2002;11:745-750
35. Izaguirre R, De La Pena, A, Ramirez A, Cortina E, Huerta M, Salazar E. Anti-Xa activity with low-molecular- weight heparin, enoxaparin, during pregnancy in women with mechanical heart valves. Proc West Pharmacol Soc 2002;45:127-128
36. Meschengieser SS, Salviu MJ, Sanchez Luceros A, et al. Low molecular weight heparin (LMWH) in pregnant women with mechanical prosthetic heart valves (MPHV). J Thromb Haemost 2003(Suppl.1):(abstract #P1479)
37. Vural KM, Ozatik MA, Uncu H, et al. Pregnancy after mechanical mitral valve replacement. J Heart Valve Dis 2003;12:370-376
38. Bauersachs R, Lindhoff-Last E. Anticoagulation of pregnant women with mechanical heart valves using low-molecular-weight heparin. Arch Intern Med 2003;163:2788-2789
39. Casele HL, Laifer SA, Woelkers DA, Venkataramanan R. Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy. Am J Obstet Gynecol 1999;181(5 Pt.1):1113-1117
40. Barbour LA, Oja JL, Schultz LK. A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation. Am J Obstet Gynecol 2004;191:1024-1029
41. Massel D, Little SH. Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: A meta-analysis. J Am Coll Cardiol 2001;37:569-578
42. Larson RJ, Fisher ES. Should aspirin be continued in patients started on warfarin? J Gen Intern Med 2004;19:879-886
43. Laffort P, Roudaut R, Roques X, et al. Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude Medical prosthesis: A clinical and transesophageal echocardiographic study. J Am Coll Cardiol 2000;35:739-746